Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-7.36M
↓ 83% below average
Average (2y)
$-4.03M
Historical baseline
Range
High:$-1.20M
Low:$-7.36M
CAGR
+147.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-7.36M | -108.4% |
| 2023 | $-3.53M | -193.3% |
| 2022 | $-1.20M | - |